These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12181642)

  • 1. The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.
    Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Lopes C
    J Hum Genet; 2002; 47(8):413-8. PubMed ID: 12181642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
    Habuchi T; Suzuki T; Sasaki R; Wang L; Sato K; Satoh S; Akao T; Tsuchiya N; Shimoda N; Wada Y; Koizumi A; Chihara J; Ogawa O; Kato T
    Cancer Res; 2000 Jan; 60(2):305-8. PubMed ID: 10667581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
    Ma J; Stampfer MJ; Gann PH; Hough HL; Giovannucci E; Kelsey KT; Hennekens CH; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):385-90. PubMed ID: 9610787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor polymorphisms and lethal prostate cancer.
    Kibel AS; Isaacs SD; Isaacs WB; Bova GS
    J Urol; 1998 Oct; 160(4):1405-9. PubMed ID: 9751364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.
    Ntais C; Polycarpou A; Ioannidis JP
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1395-402. PubMed ID: 14693728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
    Chokkalingam AP; McGlynn KA; Gao YT; Pollak M; Deng J; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
    Cancer Res; 2001 Jun; 61(11):4333-6. PubMed ID: 11389055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D receptor genotypes/haplotypes and prostate cancer risk.
    Cicek MS; Liu X; Schumacher FR; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2549-52. PubMed ID: 17164384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case-control study of the genes of receptors of the androgens of vitamin-D and of 5-alphareductase in a population of Afro-Caribbean population with prostate cancer].
    Veronique-Baudin J; Dieye M; Kouyoumdjian JC; Vacheron F; Draganescu C; Azaloux H
    Prog Urol; 2006 Jun; 16(3):303-10. PubMed ID: 16821341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer.
    John EM; Schwartz GG; Koo J; Van Den Berg D; Ingles SA
    Cancer Res; 2005 Jun; 65(12):5470-9. PubMed ID: 15958597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the vitamin D receptor gene, ultraviolet radiation, and susceptibility to prostate cancer.
    Bodiwala D; Luscombe CJ; French ME; Liu S; Saxby MF; Jones PW; Fryer AA; Strange RC
    Environ Mol Mutagen; 2004; 43(2):121-7. PubMed ID: 14991752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
    Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population.
    Huang SP; Chou YH; Wayne Chang WS; Wu MT; Chen YY; Yu CC; Wu TT; Lee YH; Huang JK; Wu WJ; Huang CH
    Cancer Lett; 2004 Apr; 207(1):69-77. PubMed ID: 15050735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.
    Xu Y; Shibata A; McNeal JE; Stamey TA; Feldman D; Peehl DM
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):23-7. PubMed ID: 12540499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population.
    Patiño-García B; Arroyo C; Rangel-Villalobos H; Soto-Vega E; Velarde-Félix JS; Gabilondo F; Sandoval-Ramirez L; Figuera LE
    Rev Invest Clin; 2007; 59(1):25-31. PubMed ID: 17569297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants in the vitamin D receptor gene and prostate cancer risk.
    Hayes VM; Severi G; Padilla EJ; Eggleton SA; Southey MC; Sutherland RL; Hopper JL; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):997-9. PubMed ID: 15824177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk.
    Andersson P; Varenhorst E; Söderkvist P
    Eur J Cancer; 2006 Nov; 42(16):2833-7. PubMed ID: 17010601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the vitamin D receptor gene and risk of lung cancer.
    Dogan I; Onen HI; Yurdakul AS; Konac E; Ozturk C; Varol A; Ekmekci A
    Med Sci Monit; 2009 Aug; 15(8):BR232-42. PubMed ID: 19644412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
    Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
    Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
    Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.
    Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
    Saudi Med J; 2004 Apr; 25(4):447-51. PubMed ID: 15083213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.